Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,214.50 -92.69 -0.61%
S&P 500 1,655.35 -13.81 -0.83%
Nasdaq 3,430.80 -32.50 -0.94%
Ticker Volume Price Price Delta
STOXX 50 2,764.29 -70.72 -2.49%
FTSE 100 6,703.10 -137.17 -2.01%
DAX 8,308.07 -222.82 -2.61%
Ticker Volume Price Price Delta
Nikkei 14,484.00 -1,143.28 -7.32%
Hang Seng 22,669.70 -591.40 -2.54%
S&P/ASX 200 5,062.45 -102.92 -1.99%
  • Exchange: NASDAQ CM
  • Sector: Communications
  • Industry: Internet
  • Sub-Industry: E-Services/Consulting

SPEX:US

7.1500 USD 0.00000.00%

As of 20:10:00 ET on 05/22/2013.

Company Profile for Spherix Inc (SPEX)

Spherix Incorporated is a biotechnology company specializing in treatments for diabetes, metabolic syndrome and atherosclerosis. The Company also provides technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies.

Contact Information

Spherix Inc

6430 Rockledge Drive
Suite 503
Bethesda, MD 20817
United States
Phone: 1-301-897-2540
Fax: 1-301-897-2567

Key Executives for Spherix Inc (SPEX)

Harvey J KesnerInterim CEORobert A Lodder JrPresident
Robert L ClaytonCFO/TreasurerKatherine M BrailerSecretary

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil